Mohawk Group Reports Fourth Quarter and Full Year 2019 Results

Mar 5, 2020

Full Year Net Revenue Grew 56.2% to $114.5 Million

NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) -- Mohawk Group Holdings, Inc. (NASDAQ: MWK) (“Mohawk”) today announced results for the fourth quarter and full year ended December 31, 2019. 

Fourth Quarter and Full Year Highlights

  • 18 new products launched in the fourth quarter, bringing 2019 full year to 32 new products launched, which have achieved, or are expected to achieve, more than $0.5 million in net revenue per year, compared to 11 in the full year 2018.
  • Full year net revenue grew 56.2% year over year to $114.5 million, and fourth quarter net revenue grew 30.1% to $25.6 million, compared to $19.7 million in the fourth quarter of 2019.
  • Full year gross margin improved to 39.4% versus 35.4% in 2018.
  • 2019 operating loss of $(38.9) million increased from $(29.4) million in 2018.
  • 2019 contribution margin grew to 2.2% from (10.6)% in 2018, reflecting both higher sustain revenues and margin expansion.
  • Excluding non-cash stock-based compensation of $19.2 million, fixed operating expenses for the full year remained essentially flat.
  • 2019 net loss of $(43.4) million increased from $(31.8) million in 2018.
  • 2019 Adjusted EBITDA improved to $(19.5) million from $(28.6) million in 2018.
  • Total cash balance at December 31, 2019 was $30.4 million.

Yaniv Sarig, Co-Founder and Chief Executive Officer, commented, “We are pleased with our fourth quarter results and our strong finish to the year. 2019 marked a year of progress on our strategic priorities that included 32 new products launched, product category expansion and the growth of our AIMEE software platform.  These activities fueled top-line growth of over 56% with improved Adjusted EBITDA for the year while we also continued to invest for the future.”

“Looking ahead, we believe that our differentiated A.I. driven business model provides Mohawk with a tremendous amount of opportunity to grow market share in existing and new categories and to generate meaningful profitability and increased shareholder value over the long-term.”

Outlook
For 2020, the Company currently expects net revenue to be in the range of $160.0 million to $170.0 million driven primarily by continued growth of its existing product portfolio and the positive contribution from new products launched in 2020. This outlook incorporates potential inventory constraints for existing products and potential delays in new product launches primarily in the second half of the year due to the impact from the COVID-19.  The Company expects positive Adjusted EBITDA for the three months ended September 30, 2020.

Non-GAAP Financial Measures

For more information on our non-GAAP financial measures and a reconciliation of GAAP to non-GAAP measures, please see the “Non-GAAP Financial Measures and Reconciliations” section below.

Webcast and Conference Call Information

Mohawk will host a live conference call to discuss financial results today, March 5, 2020, at 5:00 p.m. Eastern Time. Investors and analysts interested in participating in the call are invited to dial (877) 295-1077 (domestic) or (470) 495-9485 (international) at 5:00 p.m. ET and provide the Conference ID: 7480377. The conference call will also be available to interested parties through a live webcast at https://ir.mohawkgp.com/investor-relations. Please visit the website at least 15 minutes prior to the start of the call to register and download any necessary software.

About Mohawk Group Holdings, Inc.
Mohawk Group Holdings, Inc. and subsidiaries (“Mohawk”) is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market and sell products. Mohawk predominately operates through online retail channels such as Amazon and Walmart. Mohawk has incubated and grouped four owned and operated brands: hOme Labs, Vremi, Xtava and RIF6. Mohawk sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners), beauty related products and, to a lesser extent, consumer electronics. Mohawk was founded on the premise that if a company selling consumer packaged goods was founded today, it would apply artificial intelligence and machine learning, the synthesis of massive quantities of data and the use of social proof to validate high caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics.

Forward Looking Statements

All statements other than statements of historical facts included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements about our expected 2020 net revenue and Adjusted EBITDA, our business model and our technology platform, including our ability to disrupt the consumer products industry, our ability to grow market share in existing and new product categories; and our ability to generate profitability and shareholder value. These forward-looking statements are based on management’s current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to the impact of COVID-19, our cash flows and revenue growth rate; our supply chain, sourcing, manufacturing, warehousing and fulfillment; international tariffs and trade measures; inventory management, product liability claims, recalls or other safety concerns, reliance on third party online marketplaces, seasonal and quarterly variations in our revenue; acquisitions of other companies and technologies and other factors discussed in the “Risk Factors” section of our most recent periodic reports filed with the Securities and Exchange Commission (“SEC”), all of which you may obtain for free on the SEC’s website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, even if subsequently made available by us on our website or otherwise. We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Investor Contacts:
Ilya Grozovsky, Mohawk Group
ilya@mohawkgp.com
917-905-1699

Brendon Frey, ICR
brendon.frey@icrinc.com
203-682-8200

Media Contact:
Jessica Liddell, ICR
203-682-8200
MohawkPR@icrinc.com


MOHAWK GROUP HOLDINGS, INC.
Condensed Consolidated Statements of Operations 
(Unaudited) 
(in thousands, except share and per share data)

       
  Three Months Ended December 31,  Year-Ended December 31, 
  2018  2019  2018  2019 
NET REVENUE $19,703  $25,634  $73,279  $114,451 
COST OF GOODS SOLD  11,377   16,552   47,296   69,411 
GROSS PROFIT  8,326   9,082   25,983   45,040 
OPERATING EXPENSES:                
Research and development  845   2,476   3,655   8,133 
Sales and distribution  11,951   13,616   40,467   52,025 
General and administrative  3,187   8,003   11,290   23,782 
TOTAL OPERATING EXPENSES:  15,983   24,095   55,412   83,940 
OPERATING LOSS  (7,657)  (15,013)  (29,429)  (38,900)
INTEREST EXPENSE—net  850   1,018   2,353   4,386 
OTHER EXPENSE (INCOME)—net  31   (12)  (14)  41 
LOSS BEFORE INCOME TAXES  (8,538)  (16,019)  (31,768)  (43,327)
PROVISION FOR INCOME TAXES  52   6   55   29 
NET LOSS $(8,590) $(16,025) $(31,823) $(43,356)
Net loss per share, basic and diluted $(0.85) $(1.06) $(3.13) $(3.21)
Weighted-average number of shares outstanding, basic and diluted  10,160,879   15,134,677   10,160,879   13,516,844 


  Three Months Ended 
  31-Mar-19  30-Jun-19  30-Sep-19  31-Dec-19 
NET REVENUE $17,846  $30,368  $40,603  $25,634 
COST OF GOODS SOLD  11,175   18,608   23,076   16,552 
GROSS PROFIT  6,671   11,760   17,527   9,082 
OPERATING EXPENSES:                
Research and development  1,163   1,860   2,634   2,476 
Sales and distribution  9,274   11,828   17,307   13,616 
General and administrative  3,366   4,414   7,999   8,003 
TOTAL OPERATING EXPENSES:  13,803   18,102   27,940   24,095 
OPERATING LOSS  (7,132)  (6,342)  (10,413)  (15,013)
INTEREST EXPENSE—net  1,212   1,281   875   1,018 
OTHER EXPENSE (INCOME)—net  45   (13)  21   (12)
LOSS BEFORE INCOME TAXES  (8,389)  (7,610)  (11,309)  (16,019)
PROVISION FOR INCOME TAXES     15   8   6 
NET LOSS $(8,389) $(7,625) $(11,317) $(16,025)
Net loss per share, basic and diluted $(0.73) $(0.62) $(0.75) $(1.06)
Weighted-average number of shares outstanding, basic and diluted  11,534,190   12,206,747   15,134,422   15,134,677 
                 

MOHAWK GROUP HOLDINGS, INC.
Condensed Consolidated Balance Sheets
(Unaudited) (in thousands, except share and per share data)

       
  December 31,
2018
  December 31,
2019
 
ASSETS        
CURRENT ASSETS:        
Cash $20,029  $30,353 
Accounts receivable—net  1,403   1,059 
Inventory  30,552   36,212 
Prepaid and other current assets  5,418   5,395 
Total current assets  57,402   73,019 
PROPERTY AND EQUIPMENT—net  268   175 
GOODWILL AND OTHER INTANGIBLES—net     1,055 
OTHER NON-CURRENT ASSETS  337   175 
TOTAL ASSETS $58,007  $74,424 
LIABILITIES AND STOCKHOLDERS’ EQUITY        
CURRENT LIABILITIES:        
Credit facility $14,451  $21,657 
Accounts payable  15,404   21,064 
Term loan     3,000 
Accrued and other current liabilities  9,708   7,505 
Total current liabilities  39,563   53,226 
OTHER LIABILITIES  26   4 
TERM LOANS  13,049   10,467 
Total liabilities  52,638   63,697 
COMMITMENTS AND CONTINGENCIES        
STOCKHOLDERS’ EQUITY:        
Common stock, par value $0.0001 per share—500,000,000 shares authorized and 11,534,190 shares outstanding at December 31, 2018; 500,000,000 shares authorized and 17,736,649 shares outstanding at December 31, 2019  1   2 
Additional paid-in capital  76,348   125,044 
Accumulated deficit  (71,020)  (114,376)
Accumulated other comprehensive income  40   57 
Total stockholders’ equity  5,369   10,727 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $58,007  $74,424 
         

MOHAWK GROUP HOLDINGS, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited) (in thousands)

    
  Year-Ended December 31, 
  2018  2019 
OPERATING ACTIVITIES:        
Net loss $(31,823) $(43,356)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization  253   183 
Provision for sales returns  78   134 
Amortization of deferred financing cost and debt discounts  667   1,218 
Stock-based compensation  619   19,248 
Allowance for doubtful accounts     35 
Other  90   59 
Loss on early extinguishment on Midcap term loan  97    
Changes in assets and liabilities:        
Accounts receivable  (70)  309 
Inventory  (9,974)  (5,360)
Prepaid and other current assets  (1,153)  (1,004)
Accounts payable, accrued and other liabilities  10,871   3,263 
 Cash used in operating activities  (30,345)  (25,271)
INVESTING ACTIVITIES:        
Purchase of fixed assets  (61)  (114)
Cash consideration for acquisition of Aussie Health     (1,105)
Proceeds on sale of fixed assets  35   6 
 Cash used in investing activities  (26)  (1,213)
FINANCING ACTIVITIES:        
Proceeds from Initial Public Offering     36,000 
Issuance costs from Initial Public Offering     (5,446)
Borrowings from Mid Cap credit facility  62,665   98,663 
Repayments from Mid Cap credit facility  (50,784)  (92,165)
Debt issuance costs from Mid Cap credit facility  (926)  (581)
Debt issuance costs from Horizon term loan  (215)  (900)
Insurance financing proceeds     3,833 
Insurance obligation payments     (2,783)
Capital lease obligation payments  (54)  (55)
Capital lease financing proceeds  20    
Proceeds from issuance of Series C stock  23,969    
Proceeds from issuance of Series C-1 stock  7,660    
Issuance costs of Series C stock  (2,997)   
Issuance costs of Series C-1 stock  (1,243)   
Proceeds from exercise of stock options  18    
Repayments from Mid Cap term loan  (6,776)   
Prepayment penalty incurred with the Midcap term loan extinguishment  (97)   
Borrowings from Horizon term loan  15,000    
Deferred offering costs  (947)   
 Cash provided by financing activities  45,293   36,566 
EFFECT OF EXCHANGE RATE ON CASH  (11)  (1)
NET CHANGE IN CASH AND RESTRICTED CASH FOR THE YEAR  14,911   10,081 
CASH AND RESTRICTED CASH AT BEGINNING OF YEAR  5,797   20,708 
CASH AND RESTRICTED CASH AT END OF YEAR $20,708  $30,789 
RECONCILIATION OF CASH AND RESTRICTED CASH        
CASH $20,029   30,353 
RESTRICTED CASH—Prepaid and other current assets  550   307 
RESTRICTED CASH—Other non-current assets  129   129 
TOTAL CASH AND RESTRICTED CASH $20,708  $30,789 

Non-GAAP Financial Measures and Reconciliations

The non-GAAP financial measures contained herein are a supplement to the corresponding financial measures prepared in accordance with U.S. GAAP. The non-GAAP financial measures presented exclude the items described below. Management believes that adjustments for these items assist investors in making comparisons of period-to-period operating results. Furthermore, management also believes that these items are not indicative of the Company’s on-going core operating performance. These non-GAAP financial measures have certain limitations in that they do not reflect all of the costs associated with the operations of the Company’s business as determined in accordance with GAAP.

Therefore, investors should consider non-GAAP financial measures in addition to, and not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. The non-GAAP financial measures presented by the Company may be different from the non-GAAP financial measures used by other companies.

The Company has presented the following non-GAAP measures to assist investors in understanding the Company’s core net operating results on an on-going basis: (i) Contribution margin; (ii) Contribution margin as a percentage of net revenue; (iii) Adjusted EBITDA; and (iv) Adjusted EBITDA as a percentage of net revenue and (v) cash burn. These non-GAAP financial measures may also assist investors in making comparisons of the Company’s core operating results with those of other companies.

As used herein, Contribution margin represents operating loss plus general and administrative expenses, research and development expenses and fixed sales and distribution expenses including stock-based compensation. As used herein, Contribution margin as a percentage of net revenue represents Contribution margin divided by net revenue. As used herein, EBITDA represents net loss plus depreciation and amortization, interest expense, net and income tax expense. As used herein, Adjusted EBITDA represents EBITDA plus stock-based compensation expense and other expense, net.  As used herein, Adjusted EBITDA as a percentage of net revenue represents Adjusted EBITDA divided by net revenue. Contribution margin, EBITDA and Adjusted EBITDA do not represent and should not be considered as alternatives to loss from operations or net loss, as determined under GAAP.

We present Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue because we believe each of these measures provides an additional metric to evaluate our operations and, when considered with both our GAAP results and the reconciliation to net loss, provides useful supplemental information for investors. We use Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue, together with financial measures prepared in accordance with GAAP, such as sales and gross margins, to assess our historical and prospective operating performance, to provide meaningful comparisons of operating performance across periods, to enhance our understanding of our operating performance and to compare our performance to that of our peers and competitors.

We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue are useful to investors in assessing the operating performance of our business without the effect of non-cash items, while Contribution margin and Contribution margin as a percentage of net revenue are useful to investors in assessing the operating performance of our products as they represent our operating results without the effects of fixed costs and non-cash items.  Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue, should not be considered in isolation or as alternatives to net loss, loss from operations or any other measure of financial performance calculated and prescribed in accordance with GAAP. Neither EBITDA, Adjusted EBITDA nor Adjusted EBITDA as a percentage of net revenue should be considered a measure of discretionary cash available to us to invest in the growth of our business. Our Contribution margin, Contribution margin as a percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue may not be comparable to similar titled measures in other organizations because other organizations may not calculate Contribution margin, EBITDA, Adjusted EBITDA or Adjusted EBITDA as a percentage of net revenue in the same manner as we do. Our presentation of Contribution margin and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from such terms or by unusual or non-recurring items.

We recognize that both EBITDA, Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue, have limitations as analytical financial measures. For example, neither EBITDA nor Adjusted EBITDA reflects:

  • our capital expenditures or future requirements for capital expenditures or merger and acquisitions;

  • the interest expense or the cash requirements necessary to service interest expense or principal payments, associated with indebtedness;

  • depreciation and amortization, which are non-cash charges, although the assets being depreciated and amortized will likely have to be replaced in the future, or any cash requirements for the replacement of assets; or

  • changes in cash requirements for our working capital needs.

Additionally, Adjusted EBITDA excludes non-cash expense for stock-based compensation, which is and will remain a key element of our overall long-term incentive compensation package.

The following table represents a reconciliation of EBITDA and Adjusted EBITDA to net loss, which is the most directly comparable financial measure presented in accordance with GAAP (in thousands):

                 
  Three Months Ended
December 31,
  Year-Ended
December 31,
 
  2018  2019  2018  2019 
                 
Net loss $(8,590) $(16,025) $(31,823) $(43,356)
Add (deduct)                
Provision for income taxes  52   6   55   29 
Interest expense, net  850   1,018   2,353   4,386 
Depreciation and amortization  65   47   253   183 
EBITDA  (7,623)  (14,954)  (29,162)  (38,758)
Other expense (income), net  31   (12)  (14)  41 
Stock-based compensation  138   7,412   619   19,248 
Adjusted EBITDA $(7,454) $(7,554) $(28,557) $(19,469)
Adjusted EBITDA as a percentage of net revenue  (37.8)%  (29.5)%  (39.0)%  (17.0)%


  Three Months Ended 
  March 31,
2019
  June 30,
2019
  September 30,
2019
  December 31,
2019
 
                 
Net loss $(8,389) $(7,625) $(11,317) $(16,025)
Add (deduct)                
Provision for income taxes     15   8   6 
Interest expense, net  1,212   1,281   875   1,018 
Depreciation and amortization  55   40   41   47 
EBITDA  (7,122)  (6,289)  (10,393)  (14,954)
Other expense (income), net  45   (13)  21   (12)
Stock-based compensation  1,500   2,619   7,716   7,412 
Adjusted EBITDA $(5,577) $(3,683) $(2,656) $(7,554)
Adjusted EBITDA as a percentage of net revenue  (31.3)%  (12.1)%  (6.5)%  (29.5)%
                 

We also recognize that Contribution margin and Contribution margin as a percentage of net revenue have limitations as analytical financial measures. For example, Contribution margin does not reflect:

  • general and administrative expenses necessary to operate our business;

  • research and development expenses necessary for the development, operation and support of our software platform; or

  • the fixed costs portion of our sales and distribution expenses including stock-based compensation expense

The following table provides a reconciliation of Contribution Margin to operating loss, which is the most directly comparable financial measure presented in accordance with GAAP (in thousands):

  Three Months Ended  December 31,  Year-Ended December 31, 
  2018  2019  2018  2019 
                 
Operating loss $(7,657) $(15,013) $(29,429)  (38,900)
Add                
General and administrative expenses  3,187   8,003   11,290   23,782 
Research and development expenses  845   2,476   3,655   8,133 
Sales and distribution fixed expenses, including stock-based compensation expense within sales and distribution expense  2,642   2,852   6,695   9,475 
Contribution margin $(983) $(1,682) $(7,789) $2,490 
Contribution margin as a percentage of net revenue  (5.0)%  (6.6)%  (10.6)%  2.2%


  Three Months Ended
  March 31, 2019  June 30, 2019  September 30, 2019  December 31, 2019  
       
Operating loss $(7,132) $(6,342) $(10,413)  (15,013)
Add                
General and administrative expenses  3,366   4,414   7,999   8,003 
Research and development expenses  1,163   1,860   2,634   2,476 
Sales and distribution fixed expenses, including stock-based compensation expense within sales and distribution expense  1,807   1,804   3,010   2,852 
Contribution margin $(794) $1,736  $3,230  $(1,682)
Contribution margin as a percentage of net revenue  (4.5)%  5.7%  8.0%  (6.6)%

  We believe each of our products goes through three core phases as follows:

  1. Launch phase: During this phase, we leverage our technology to target opportunities identified using AIMEE. During this period of time, and due to the combination of discounts and investment in marketing, our net margin for a product could be as low as negative 35%. In general, a product may stay in the launch phase on average for 3 months.
  2. Sustain phase: Our goal is for every product we launch to enter the sustain phase and become profitable, with a target average of positive 10% net margin (i.e. contribution margin). Over time, our products benefit from economies of scale stemming from purchasing power both with manufacturers and with fulfillment providers.
  3. Liquidate phase: If a product does not enter the sustain phase or if the customer satisfaction of the product (i.e., ratings) are not satisfactory, then it will go to the liquidate phase and we will sell the remaining inventory.

The following table breaks out our quarterly results of operations by our product phases including our SaaS business line:

  Three Months Ended March 31, 2019 (in thousands)
  Sustain  Launch  SaaS  Liquidate
/Other
  Fixed
Costs
  Stock-based
compensation
expense
  Total
NET REVENUE $13,296  $2,602  $630  $1,318  $  $  $17,846
COST OF GOODS SOLD  8,322   1,743      1,110         11,175
GROSS PROFIT  4,974   859   630   208         6,671
OPERATING EXPENSES:                           
Sales and distribution expense  5,077   1,343   166   880   1,420   388   9,274
Research and development expense              1,002   161   1,163
General and administrative expense              2,415   951   3,366


  Three Months Ended June 30, 2019  (in thousands)
  Sustain  Launch  SaaS  Liquidate
/Other
  Fixed
Costs
  Stock-based
compensation
expense
  Total
NET REVENUE $27,464  $1,405  $425  $1,074  $  $  $30,368
COST OF GOODS SOLD  16,810   932      866         18,608
GROSS PROFIT  10,654   473   425   208         11,760
OPERATING EXPENSES:                           
Sales and distribution expense  8,651   590   110   673   1,276   528   11,828
Research and development expense              1,470   390   1,860
General and administrative expense              2,713   1,701   4,414


  Three Months Ended September 31, 2019  (in thousands)
  Sustain  Launch  SaaS  Liquidate
/Other
  Fixed
Costs
  Stock-based
compensation
expense
  Total
NET REVENUE $36,162  $2,771  $316  $1,354  $  $  $40,603
COST OF GOODS SOLD  21,801   1,983      (708)        23,076
GROSS PROFIT  14,361   788   316   2,062         17,527
OPERATING EXPENSES:                           
Sales and distribution expense  11,249   1,637   138   1,273   1,393   1,617   17,307
Research and development expense              1,307   1,327   2,634
General and administrative expense              3,227   4,772   7,999


  Three Months Ended December 31, 2019  (in thousands)
  Sustain  Launch  SaaS  Liquidate
/Other
  Fixed
Costs
  Stock-based
compensation
expense
  Total
NET REVENUE $20,326  $3,026  $310  $1,972  $  $  $25,634
COST OF GOODS SOLD  11,945   1,821      2,786         16,552
GROSS PROFIT  8,381   1,205   310   (814)        9,082
OPERATING EXPENSES:                           
Sales and distribution expense  7,096   1,635   141   1,892   1,208   1,644   13,616
Research and development expense              1,172   1,304   2,476
General and administrative expense              3,542   4,461   8,003


  Year-Ended December 31, 2019
  Sustain  Launch  SaaS  Liquidation
/Other
  Fixed
Costs
  Stock based
compensation
expense
  Total
NET REVENUE $97,248  $9,804  $1,681  $5,718  $  $  $114,451
COST OF GOODS SOLD  58,878   6,479      4,054         69,411
GROSS PROFIT $38,370  $3,325  $1,681  $1,664  $  $  $45,040
                            
OPERATING EXPENSES:                           
Sales and distribution expenses  32,073   5,205   555   4,717   5,298   4,177   52,025
Research and development              4,951   3,182   8,133
General and administrative              11,897   11,885   23,782
                            

Quarterly Condensed Statement of Cash Flows Information

The following table provides summarized quarterly information from our condensed statement of cash flows for 2019:

  Three Months Ended 
  March 31,
2019
  June 30,
2019
  September 30,
2019
  December 31,
2019
 
Operating activities:                
Net loss $(8,389) $(7,625) $(11,317) $(16,025)
Total adjustments to reconcile net loss to net cash used in operating activities  1,879   3,219   8,124   7,655 
Cash (used in) provided by working capital (changes in assets and liabilities)  (5,413)  41   6,337   (3,754)
Cash used in operating activities  (11,923)  (4,365)  3,144   (12,124)
                 
Cash used in investing activities  (10)  (11)  (1,126)  (66)
                 
Financing activities:                
Proceeds from initial public offering, less issuance costs    30,902   (348)   
Net proceeds from (payments to) MidCap Credit Facility  5,520   (1,617)  (5,244)  7,839 
All other financing activities  (893)  1,652   (266)  (980)
Cash provided by (used in) financing activities  4,627   30,937   (5,858)  6,859 
Effect of exchange rate on cash 1  0   (1)  (1)
Net change in cash and restricted cash for period $(7,305) $26,561  $(3,841) $(5,332)

As used herein, cash burn represents the change of the net change in cash balance at each of the balance sheet period adjusted for certain one-time items like the initial public offering and excluding changes in restricted cash. We use cash burn to provide an additional metric to evaluate our cash flows from our business operations. We believe cash burn is useful to investors to evaluate the cash operating performance of our business without the effect of certain one-time items (i.e., the initial public offering).   Our method for calculating cash burn may not be used by other organizations and therefore our cash burn amount may not be directly comparable to the cash burn disclosed by other organizations. The following table provides a reconciliation of cash burn to the net change in cash and restricted cash for period, which is the most directly comparable financial measure presented in accordance with GAAP:

  Three Months Ended 
  March 31,
2019
  June 30,
2019
  September 30,
2019
  December 31,
2019
 
                 
Net change in cash and restricted cash for period $(7,305) $26,561  $(3,841) $(5,332)
Less:                
Proceeds from initial public offering, less issuance costs    (30,902) 348  0 
Net cash impact from mergers and acquisition activity      1,105  0 
Changes in restricted cash 250      0 
Cash burn $(7,055) $(4,341) $(2,388) $(5,332)